Uri A. Lopatin - 23 Dec 2021 Form 3 Insider Report for PARDES BIOSCIENCES, INC.

Role: President and CEO, Director
Signature: /s/ Elizabeth Lacy, attorney-in-fact
Issuer symbol: N/A
Transactions as of: 23 Dec 2021
Net transactions value: $0
Form type: 3
Filing time: 27 Dec 2021, 16:31:55 UTC
Next filing: 02 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	PRDS	Common Stock						5,327,798	23 Dec 2021	Direct
holding	PRDS	Common Stock						351,948	23 Dec 2021	See footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person and his spouse are co-trustees of the Lopatin Descendants' Trust (the "Trust"). The Reporting Person disclaims Section 16 beneficial ownership of the securities held by the Trust, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.

Content

The reporting person and his spouse are co-trustees of the Lopatin Descendants' Trust (the "Trust"). The Reporting Person disclaims Section 16 beneficial ownership of the securities held by the Trust, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.

Remarks:

Exhibit 24 - Power of Attorney Effective immediately following the effective time of the merger pursuant to that certain Agreement and Plan of Merger dated as of June 29, 2021, as amended, by and among Pardes Biosciences Sub, Inc. (f/k/a Pardes Biosciences, Inc.), Issuer (f/k/a FS Development Corp. II), and certain other parties thereto, the reporting person became a director and an officer of the Issuer.